Rett syndrome is a dubious disease in the field of the nervous system, with clinical performance being complex and often involving multi-system congestion. Early identification and normalisation of clinical trials are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
A comprehensive assessment platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. Treatment and management of Rett syndrome requires individual development of treatment regimens, typically including drug therapy, rehabilitation intervention, and regular follow-up to multiple-dimensional management. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many of the neural system disorders that have previously been difficult to treat have improved significantly.
Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely scheduling according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of Rett syndrome. The platform serves a team of domestic and foreign experts in the field of neural systems related to the China International Medical Service System, providing the following services to patients: 1.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.